The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. It partners with international organisations, civil society, patient groups, industry and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. MPP has signed agreements with ten patent holders for thirteen HIV medicines, one HIV technology platform, three hepatitis C direct-acting antivirals and one tuberculosis treatment. MPP was founded by Unitaid, which serves as sole funder for MPP’s activities in HIV, hepatitis C and tuberculosis.